These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

279 related items for PubMed ID: 25767211

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. In-vitro and in-vivo inhibition of melanoma growth and metastasis by the drug combination of celecoxib and dacarbazine.
    Sadhu SS, Wang S, Averineni RK, Seefeldt T, Yang Y, Guan X.
    Melanoma Res; 2016 Dec; 26(6):572-579. PubMed ID: 27540834
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. A combination of photodynamic therapy and chemotherapy displays a differential cytotoxic effect on human metastatic melanoma cells.
    Biteghe FN, Davids LM.
    J Photochem Photobiol B; 2017 Jan; 166():18-27. PubMed ID: 27852006
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Combined treatment with Ad-hTRAIL and DTIC or SAHA is associated with increased mitochondrial-mediated apoptosis in human melanoma cell lines.
    Lillehammer T, Engesaeter BO, Prasmickaite L, Maelandsmo GM, Fodstad O, Engebraaten O.
    J Gene Med; 2007 Jun; 9(6):440-51. PubMed ID: 17410615
    [Abstract] [Full Text] [Related]

  • 10. Oncolytic adenovirus expressing interleukin-18 improves antitumor activity of dacarbazine for malignant melanoma.
    Yang C, Cao H, Liu N, Xu K, Ding M, Mao LJ.
    Drug Des Devel Ther; 2016 Jun; 10():3755-3761. PubMed ID: 27895465
    [Abstract] [Full Text] [Related]

  • 11. Nodal induced by hypoxia exposure contributes to dacarbazine resistance and the maintenance of stemness in melanoma cancer stem‑like cells.
    Li H, Chen J, Wang X, He M, Zhang Z, Cen Y.
    Oncol Rep; 2018 Jun; 39(6):2855-2864. PubMed ID: 29693169
    [Abstract] [Full Text] [Related]

  • 12. MGMT expression levels predict disease stabilisation, progression-free and overall survival in patients with advanced melanomas treated with DTIC.
    Busch C, Geisler J, Lillehaug JR, Lønning PE.
    Eur J Cancer; 2010 Jul; 46(11):2127-33. PubMed ID: 20541396
    [Abstract] [Full Text] [Related]

  • 13. Radioimmunotherapy of experimental human metastatic melanoma with melanin-binding antibodies and in combination with dacarbazine.
    Revskaya E, Jongco AM, Sellers RS, Howell RC, Koba W, Guimaraes AJ, Nosanchuk JD, Casadevall A, Dadachova E.
    Clin Cancer Res; 2009 Apr 01; 15(7):2373-9. PubMed ID: 19293257
    [Abstract] [Full Text] [Related]

  • 14. Dacarbazine-based chemotherapy for metastatic melanoma: thirty-year experience overview.
    Serrone L, Zeuli M, Sega FM, Cognetti F.
    J Exp Clin Cancer Res; 2000 Mar 01; 19(1):21-34. PubMed ID: 10840932
    [Abstract] [Full Text] [Related]

  • 15. DR5 mAb-conjugated, DTIC-loaded immuno-nanoparticles effectively and specifically kill malignant melanoma cells in vivo.
    Ding B, Zhang W, Wu X, Wang J, Xie C, Huang X, Zhan S, Zheng Y, Huang Y, Xu N, Ding X, Gao S.
    Oncotarget; 2016 Aug 30; 7(35):57160-57170. PubMed ID: 27494835
    [Abstract] [Full Text] [Related]

  • 16. Protocatechuic aldehyde acts synergistically with dacarbazine to augment DNA double-strand breaks and promote apoptosis in cutaneous melanoma cells.
    Pei J, Su Z, Zeng X, Zhong Y, Zhang Y, Yang Y, Lu Q, Li J, Deng Y.
    BMC Complement Med Ther; 2023 Apr 06; 23(1):111. PubMed ID: 37024907
    [Abstract] [Full Text] [Related]

  • 17. Combination of dacarbazine and dimethylfumarate efficiently reduces melanoma lymph node metastasis.
    Valero T, Steele S, Neumüller K, Bracher A, Niederleithner H, Pehamberger H, Petzelbauer P, Loewe R.
    J Invest Dermatol; 2010 Apr 06; 130(4):1087-94. PubMed ID: 19940857
    [Abstract] [Full Text] [Related]

  • 18. Desensitization of metastatic melanoma cells to therapeutic treatment through repeated exposure to dacarbazine.
    Biteghe FAN, Padayachee E, Davids LM, Chalomie NET, Ndong JC, Barth S.
    J Photochem Photobiol B; 2020 Oct 06; 211():111982. PubMed ID: 32866820
    [Abstract] [Full Text] [Related]

  • 19. Anti-melanoma activity of the 9.2.27PE immunotoxin in dacarbazine resistant cells.
    Risberg K, Fodstad O, Andersson Y.
    J Immunother; 2010 Apr 06; 33(3):272-8. PubMed ID: 20445347
    [Abstract] [Full Text] [Related]

  • 20. Dacarbazine causes transcriptional up-regulation of interleukin 8 and vascular endothelial growth factor in melanoma cells: a possible escape mechanism from chemotherapy.
    Lev DC, Ruiz M, Mills L, McGary EC, Price JE, Bar-Eli M.
    Mol Cancer Ther; 2003 Aug 06; 2(8):753-63. PubMed ID: 12939465
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.